摘要
COVID-19,an infectious disease caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),has spread throughout the world.China has achieved rapid containment of this highly infectious disease following the principles of early detection,early quarantine and early treatment with integrated traditional Chinese and Western medicine.The inclusion of traditional Chinese medicine(TCM)in the Chinese protocol is based on its successful historic experience in fighting against pestilence.Current findings have shown that the Chinese medicine can reduce the incidence of severe or critical events,improve clinical recovery and help alleviate symptoms such as cough or fever.To date there are over 133 ongoing registered clinical studies on TCM/integrated traditional Chinese and Western medicine.The three Chinese patent medicines(Lianhua Qingwen Keli/Jiaonang(Forsythiae and Honeysuckle Flower Pestilence-Clearing Granules/Capsules),Jinhua Qinggan Keli(Honeysuckle Flower ColdRelieving Granules)and Xuebijing(Stasis-Resolving&Toxin-Removing)Injection were officially approved by the National Medical Products Administration to list COVID-19 as an additional indication.The pharmacological studies have suggested that Chinese medicine is effective for COVID-19 probably through its host-directed regulation and certain antiviral effects.
基金
sponsored by National Science and Technology Major Project“GCP platform construction for Chinese medicine prevention and control of infectious diseases”(2017ZX09304002,China)
Scientific Research Project of Shanghai Municipal Health Commission on Traditional Chinese Medicine for Prevention and Treatment of COVID-19(2020XGKY07,China)
Emergency Scientific Research Programme of Shanghai University of Traditional Chinese Medicine(2019YJ 06,China)
作者简介
Corresponding author:Weian Yuan,E-mail addresses:weian_1980@163.com;Corresponding author:Hongzhuan Chen,E-mail addresses:yaoli@shsmu.edu.cn
